Literature DB >> 29863928

HIV Treatment Substantially Decreases Hospitalization Rates: Evidence From Rural South Africa.

Jan A C Hontelez1, Jacob Bor2, Frank C Tanser3, Deenan Pillay4, Mosa Moshabela5, Till Bärnighausen6.   

Abstract

The effect of HIV treatment on hospitalization rates for HIV-infected people has never been established. We quantified this effect in a rural South African community for the period 2009-13. We linked clinical data on HIV treatment start dates for more than 2,000 patients receiving care in the public-sector treatment program with five years of longitudinal data on self-reported hospitalizations from a community-based population cohort of more than 100,000 adults. Hospitalization rates peaked during the first year of treatment and were about five times higher, compared to hospitalization rates after four years on treatment. Earlier treatment initiation could save more than US$300,000 per 1,000 patients over the first four years of HIV treatment, freeing up scarce resources. Future studies on the cost-effectiveness of HIV treatment should include these effects.

Entities:  

Keywords:  AIDS/HIV; Cost of Health Care; International/global health studies; Public Health; Rural Health Care

Mesh:

Substances:

Year:  2018        PMID: 29863928      PMCID: PMC6813771          DOI: 10.1377/hlthaff.2017.0820

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   9.048


  33 in total

Review 1.  Self-reported utilization of health care services: improving measurement and accuracy.

Authors:  Aman Bhandari; Todd Wagner
Journal:  Med Care Res Rev       Date:  2006-04       Impact factor: 3.929

2.  Fixed effects analysis of repeated measures data.

Authors:  Fiona Imlach Gunasekara; Ken Richardson; Kristie Carter; Tony Blakely
Journal:  Int J Epidemiol       Date:  2013-12-23       Impact factor: 7.196

3.  The cost of providing comprehensive HIV treatment in PEPFAR-supported programs.

Authors:  Nicolas A Menzies; Andres A Berruti; Richard Berzon; Scott Filler; Robert Ferris; Tedd V Ellerbrock; John M Blandford
Journal:  AIDS       Date:  2011-09-10       Impact factor: 4.177

4.  Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

Authors:  Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

5.  Antiretroviral Therapy for the Prevention of HIV-1 Transmission.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Leslie Cottle; Xinyi C Zhang; Joseph Makhema; Lisa A Mills; Ravindre Panchia; Sharlaa Faesen; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David D Celentano; Max Essex; Sarah E Hudelson; Andrew D Redd; Thomas R Fleming
Journal:  N Engl J Med       Date:  2016-07-18       Impact factor: 91.245

6.  Dramatic increase in HIV prevalence after scale-up of antiretroviral treatment.

Authors:  Jaffer Zaidi; Erofili Grapsa; Frank Tanser; Marie-Louise Newell; Till Bärnighausen
Journal:  AIDS       Date:  2013-09-10       Impact factor: 4.177

7.  Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.

Authors:  Jeffrey W Eaton; Nicolas A Menzies; John Stover; Valentina Cambiano; Leonid Chindelevitch; Anne Cori; Jan A C Hontelez; Salal Humair; Cliff C Kerr; Daniel J Klein; Sharmistha Mishra; Kate M Mitchell; Brooke E Nichols; Peter Vickerman; Roel Bakker; Till Bärnighausen; Anna Bershteyn; David E Bloom; Marie-Claude Boily; Stewart T Chang; Ted Cohen; Peter J Dodd; Christophe Fraser; Chaitra Gopalappa; Jens Lundgren; Natasha K Martin; Evelinn Mikkelsen; Elisa Mountain; Quang D Pham; Michael Pickles; Andrew Phillips; Lucy Platt; Carel Pretorius; Holly J Prudden; Joshua A Salomon; David A M C van de Vijver; Sake J de Vlas; Bradley G Wagner; Richard G White; David P Wilson; Lei Zhang; John Blandford; Gesine Meyer-Rath; Michelle Remme; Paul Revill; Nalinee Sangrujee; Fern Terris-Prestholt; Meg Doherty; Nathan Shaffer; Philippa J Easterbrook; Gottfried Hirnschall; Timothy B Hallett
Journal:  Lancet Glob Health       Date:  2013-12-10       Impact factor: 26.763

8.  HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions.

Authors:  Gesine Meyer-Rath; Mead Over
Journal:  PLoS Med       Date:  2012-07-10       Impact factor: 11.069

9.  Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa.

Authors:  Jacob Bor; Matthew P Fox; Sydney Rosen; Atheendar Venkataramani; Frank Tanser; Deenan Pillay; Till Bärnighausen
Journal:  PLoS Med       Date:  2017-11-28       Impact factor: 11.613

10.  The Effect of Antiretroviral Treatment on Health Care Utilization in Rural South Africa: A Population-Based Cohort Study.

Authors:  Jan A C Hontelez; Frank C Tanser; Kevindra K Naidu; Deenan Pillay; Till Bärnighausen
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.